BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16723104)

  • 1. Health care resource use for uterine fibroid tumors in the United States.
    Flynn M; Jamison M; Datta S; Myers E
    Am J Obstet Gynecol; 2006 Oct; 195(4):955-64. PubMed ID: 16723104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
    Goldberg J; Bussard A; McNeil J; Diamond J
    Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
    Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
    J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
    Becker ER
    J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of uterine fibroids in the United States: a summary of published estimates.
    Mauskopf J; Flynn M; Thieda P; Spalding J; Duchane J
    J Womens Health (Larchmt); 2005 Oct; 14(8):692-703. PubMed ID: 16232101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
    Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
    J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual costs associated with diagnosis of uterine leiomyomata.
    Hartmann KE; Birnbaum H; Ben-Hamadi R; Wu EQ; Farrell MH; Spalding J; Stang P
    Obstet Gynecol; 2006 Oct; 108(4):930-7. PubMed ID: 17012456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine fibroid treatment patterns in a population of insured women.
    Lee DW; Gibson TB; Carls GS; Ozminkowski RJ; Wang S; Stewart EA
    Fertil Steril; 2009 Feb; 91(2):566-74. PubMed ID: 18304543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013.
    Soliman AM; Yang H; Du EX; Kelkar SS; Winkel C
    Am J Obstet Gynecol; 2015 Aug; 213(2):141-60. PubMed ID: 25771213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
    Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
    Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid.
    Oderda G; Asche C; Jones KP; Merrill RM; Spalding J
    Arch Gynecol Obstet; 2007 Sep; 276(3):211-8. PubMed ID: 17342498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct medical costs of constipation in the United States.
    Martin BC; Barghout V; Cerulli A
    Manag Care Interface; 2006 Dec; 19(12):43-9. PubMed ID: 17274481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.
    Beinfeld MT; Bosch JL; Isaacson KB; Gazelle GS
    Radiology; 2004 Jan; 230(1):207-13. PubMed ID: 14695395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization costs associated with leiomyoma.
    Zhao SZ; Wong JM; Arguelles LM
    Clin Ther; 1999 Mar; 21(3):563-75. PubMed ID: 10321423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
    Bennett CL; Calhoun EA
    Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine fibroid tumors: diagnosis and treatment.
    Evans P; Brunsell S
    Am Fam Physician; 2007 May; 75(10):1503-8. PubMed ID: 17555142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up.
    Lohle PN; De Vries J; Klazen CA; Boekkooi PF; Vervest HA; Smeets AJ; Lampmann LE; Kroencke TJ
    J Vasc Interv Radiol; 2007 Jul; 18(7):835-41. PubMed ID: 17609441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine fibroid embolization: a viable alternative to hysterectomy.
    Bradley LD
    Am J Obstet Gynecol; 2009 Aug; 201(2):127-35. PubMed ID: 19646564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality control and quality of life after uterine fibroid embolization: long-term results].
    Hirzel F; Hess T; Zollikofer C
    Gynakol Geburtshilfliche Rundsch; 2008; 48(2):84-93. PubMed ID: 18431048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.